Sylvania Platinum Limited (SLP)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 90.20 |
|---|---|
| 52-week range | 71.90 – 130.00 |
| Return, 1 month / 3 months | −8.0% / +6.1% |
| Return, 1 year / 3 years | +16.1% / +44.3% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 48.9% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 82.06M GBX |
| Dividend yield | 4.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sylvania Platinum is a platinum group metals producer whose main activity is recovering metals from chrome tailings and other material at its operations in South Africa. The company processes these dumps to extract platinum, palladium, rhodium and gold, and it also explores for and develops platinum group metal deposits. Its customers are the refiners and metal traders that take the concentrate it produces. The business is incorporated in Bermuda, while its mining and processing work is carried out in South Africa.
On this site Sylvania Platinum Limited appears as a stock on the London Stock Exchange (UK), code SLP, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sylvania Platinum Limited (SLP) trades on the London Stock Exchange in UK. It last closed at GBX 90.20 on 27 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,980 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.1% and over the last three months it rose 6.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.5% | ||
| From 52-week high | -29.3% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.1% | ||
| 6-month return | -8.0% | ||
| 12-month return, skipping the last month | 26.1% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 82.06M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.4% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −8.0% |
| 3 months | +6.1% |
| 6 months | −8.0% |
| 1 year | +16.1% |
| 3 years | +44.3% |
| 5 years | +16.9% |
Signals
| 50-day / 200-day average | 92.34 / 96.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Oct 2026 | GBP 0.0400 |
| 5 Mar 2026 | GBP 0.0200 |
| 30 Oct 2025 | GBP 0.0200 |
| 27 Feb 2025 | GBP 0.0075 |
| 31 Oct 2024 | GBP 0.0100 |
| 9 May 2024 | GBP 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.